Quest Partners LLC Acquires New Position in Semler Scientific, Inc. (NASDAQ:SMLR)

Quest Partners LLC bought a new position in Semler Scientific, Inc. (NASDAQ:SMLR) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,703 shares of the company’s stock, valued at approximately $59,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. CWM LLC increased its position in shares of Semler Scientific by 486.3% during the second quarter. CWM LLC now owns 897 shares of the company’s stock valued at $31,000 after acquiring an additional 744 shares in the last quarter. Rhumbline Advisers increased its holdings in shares of Semler Scientific by 27.1% in the 2nd quarter. Rhumbline Advisers now owns 6,197 shares of the company’s stock worth $213,000 after purchasing an additional 1,320 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of Semler Scientific by 10.4% in the second quarter. Bank of New York Mellon Corp now owns 20,618 shares of the company’s stock worth $709,000 after purchasing an additional 1,940 shares during the last quarter. Horizon Investment Services LLC lifted its holdings in shares of Semler Scientific by 35.8% during the first quarter. Horizon Investment Services LLC now owns 8,352 shares of the company’s stock valued at $244,000 after purchasing an additional 2,203 shares in the last quarter. Finally, Greenwood Capital Associates LLC boosted its position in shares of Semler Scientific by 38.1% during the first quarter. Greenwood Capital Associates LLC now owns 21,883 shares of the company’s stock valued at $639,000 after buying an additional 6,036 shares during the last quarter. Institutional investors own 49.37% of the company’s stock.

Insider Buying and Selling at Semler Scientific

In other news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the firm’s stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $28.35, for a total value of $283,500.00. Following the transaction, the chief executive officer now directly owns 60,220 shares in the company, valued at approximately $1,707,237. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 13.00% of the company’s stock.

Semler Scientific Stock Performance

NASDAQ SMLR opened at $24.79 on Thursday. The company has a market capitalization of $175.17 million, a price-to-earnings ratio of 8.89 and a beta of 0.96. The stock has a 50-day moving average of $29.01 and a 200 day moving average of $29.52. Semler Scientific, Inc. has a one year low of $20.88 and a one year high of $53.38.

Semler Scientific (NASDAQ:SMLR) last announced its quarterly earnings results on Monday, August 5th. The company reported $0.64 EPS for the quarter, topping analysts’ consensus estimates of $0.56 by $0.08. Semler Scientific had a net margin of 25.62% and a return on equity of 21.17%. The firm had revenue of $14.47 million during the quarter.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.